Lymphocytic choriomeningitis virus (LCMV) naturally infects and replicates in the murine host. Work from a number of laboratories has demonstrated that infection of adult mice with LCMV by intraperitoneal (i.p.) or intravenous (i.v.) inoculation usually leads to the generation of a protective immune response and clearance of infectious virus (4, 5) . In contrast, a similar dose of virus inoculated intracerebrally causes an immune-mediated choriomeningitis and death (14) . This viral infection provides an excellent model to study how the interaction of a virus with the host immune system can lead to a protective immune response and clearance of viral infection or, alternatively, to virusinduced immune response disease (1, 2, 4, 5, 7, 18, 19, 27) . Experiments with LCMV have provided important insights toward understanding cell-mediated immune responses generated against viral infection (27) and the role that these activities play both during recovery from infection and during mediation of pathological processes (6, 9, 11, 24) .
Upon infection of immunocompetent adult animals, a potent cytotoxic T lymphocyte (CTL) response is generated (7, 16) . By using LCMV as a model, it was first demonstrated that the CTL response is virus specific (16) as well as H-2 restricted (25, 26) in its activity. In later studies, the importance of a T cell-mediated response in the clearance of infectious virus (17) and in the induction of immune-mediated disease has been demonstrated (6, 11, 24) . Mims and Blanden (17) and Zinkernagel and Welsh (27) have shown that spleen cells taken from adult mice 7 to 8 days after they were inoculated with LCMV and adoptively transferred to acutely infected mice cleared virus from the infected mice. The same activated spleen cell population has been demonstrated to transfer the viral-induced immune response disease when injected into immunocompetent adult mice that were inoculated intracerebrally with LCMV (11) . In both cases, a necessary cell population in the preparation was found to be the T lymphocytes, which were only effective when donors and recipients shared H-2K or H-2D region specificities (6, 9, 27) . However, because heterogeneous populations of primed T cells rather than homogeneous cloned populations were used, the exact nature of LCMVspecific T cell(s) or other lymphocytes involved directly or indirectly in these processes could not be clearly established. The development of techniques for in vitro cloning and long-term culture of T lymphocytes now allows us to obtain large numbers of homogeneous cloned T cells with specific functions (12, 13, 23) . These homogeneous populations can be used to ask questions concerning the specific contributions of various T lymphocyte subsets to the control of viral infection or, alternatively, the induction of pathological processes. The information obtained would add to our understanding of the pathogenesis of viral infections as well as aid us in devising appropriate immunization protocols to protect against viral infection. Such CTL clones could also be of value as unique tools for defining CTL trafficking and target homing as well as probes to uncover the molecular basis of CTL-mediated activity in vivo.
Here we report the first demonstration that LCMV-specific, H-2-restricted CTL clones can act in vivo and demonstrate their ability to clear infectious virus from acutely infected mice.
MATERIALS AND METHODS
Virus stock and assay for virus PFU. The Armstrong CA 1371 strain of LCMV (LCMV Arm) was used in all experiments. Virus was plaque purified on Vero cells, virus stocks were grown in BHK cells, and titers of virus stocks were determined on Vero cell monolayers as previously described (3) . Spleens whose titers were to be determined for infectious virus were removed asceptically and frozen in Eagle minimal essential medium supplemented with 10% fetal bovine serum (heat inactivated at 56°C for 30 min), 1 mMand centrifuged (1,000 rpm for 10 min at 4°C) to remove all debris, and the titers of the supernatants were determined on Vero cell monolayers as previously described (3 104) were mixed with washed (two times) effector cells at the designated effector-to-target ratio in 0.2 ml of RPMI-S supplemented with 10% heat-inactivated fetal bovine serum, 1 mM glutamine, penicillin, and streptomycin in 96-well flat-bottom plates. In place of effectors, 100 p1l of RPMI-S medium was used to measure spontaneous lysis and 100 of 1% Nonidet P-40 was used to measure total lysis. Plates were incubated for 6 h at 37°C and centrifuged at 500 rpm at 4°C for 5 min, after which 0.1-mI fractions of the supernatant were collected and counted for radioactivity. (Table 2) .
However, these virus titers were significantly reduced by adoptive transfer of 108 spleen cells from mice injected 7 days previously with LCMV (7-day immune spleen cells) but not by adoptive transfer of an equal number of normal spleen cells, which confirms previous reports (27) . Adoptive transfer of 8 x 106 CTLs of clone 11-5 reduced the titers of infectious virus in the spleens of recipient mice by at least 99% (Table 2) , thus demonstrating that cloned T lymphocytes with cytotoxic activity in vitro mediate a biologically relevant effect in vivo in acutely infected animals.
To test whether transfer of cloned CTLs could maintain the clearance of virus for a period of time, mice were adoptively transferred with cloned CTLs 24 h after infection with LCMV and sacrificed at 2, 4, and 5 days postinfection (1, 3, and 4 days, respectively, after adoptive transfer of cloned CTLs) ( Table 1 ]), we next tested the genetic restriction of the activity of this clone in vivo in two experiments ( Table 4) . As in the previous experiments, injection of C57BL/6 mice with clone 11-5 or 7-day immune spleen cells resulted in significant reductions of virus titers. In contrast, clone 11-5 did not lower virus titers in the spleens of acutely infected allogeneic BALB/c mice. Thus, clone 11-5 is only capable of eliminating infectious virus when functioning in the appropriate genetic environment, presumably involving, recognition of viral antigen in the context of the proper H-2 gene products. The fact that syngeneic immune spleen cells injected into BALB/c mice decreased titers of infectious virus demonstrates that BALB/c LCMV-immune spleen cells also contain a population of cells capable of eliminating infectious virus from the BALB/c recipient within the same time period. The inability of clone 11-5 to reduce virus titers in the allogeneic recipient was not due to the fact that LCMVimmune cells were unable to function similarly in infected BALB/c mice. 
